The only stem cell study combining two proven delivery approaches for bone marrow-derived stem cells to the central and peripheral nervous systems. Multiple neurologic conditions are eligible, but the largest categories include chronic Stroke (CVA), Parkinson’s Disease, Traumatic Brain Injury, Multiple Sclerosis, and Peripheral Neuropathy. Our initial patients with Parkinson’s have reported improvements following treatment including: balance, facial musculature, loss of mask appearance, fine muscle control, posture, gate and speed of walking, reduced fatigue and depression, improvement in sleep.
Other conditions have also improved. Patients typically receive intravenous and intranasal bone marrow stem cells. The procedure is performed as an outpatient at the ParkCreek Surgery Center under general or MAC anesthesia by board-certified anesthesiologists. Bone marrow aspiration is painless and performed by our board-certified orthopedic surgeon. A 3-night stay is required in the area to allow a preop day, procedure day, and postop visit. Patients may return home the postop day, and flying is perfectly fine. Cost is USD $17,000.00. Please see www.clinicaltrials.gov NCT 02795052.